Man Group plc Invests $1.40 Million in Phreesia, Inc. $PHR

Man Group plc acquired a new stake in shares of Phreesia, Inc. (NYSE:PHR) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm acquired 135,584 shares of the company’s stock, valued at approximately $1,395,000. Man Group plc owned 0.22% of Phreesia at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of PHR. EverSource Wealth Advisors LLC boosted its holdings in Phreesia by 1,119.8% in the 1st quarter. EverSource Wealth Advisors LLC now owns 3,269 shares of the company’s stock worth $27,000 after buying an additional 3,001 shares during the period. Van ECK Associates Corp raised its holdings in Phreesia by 78.7% during the fourth quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock valued at $42,000 after acquiring an additional 1,102 shares during the period. New York State Teachers Retirement System bought a new stake in Phreesia during the first quarter valued at about $44,000. Rockefeller Capital Management L.P. lifted its position in shares of Phreesia by 354.6% in the fourth quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock valued at $47,000 after acquiring an additional 2,149 shares in the last quarter. Finally, Allworth Financial LP purchased a new position in shares of Phreesia in the second quarter valued at about $58,000. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Key Phreesia News

Here are the key news stories impacting Phreesia this week:

• Positive Sentiment: Phreesia generated positive operating and free cash flow for the quarter and reduced debt principal by more than $23 million, strengthening its balance sheet and supporting profitability expansion. Phreesia Announces Second Quarter Fiscal 2027 Results
• Positive Sentiment: Management maintained fiscal 2027 revenue guidance of $510 million to $520 million, broadly in line with the $515 million analyst consensus, reducing the risk of a near-term outlook cut. The company also identified AccessOne as a potential multi-year growth driver. Phreesia maintains FY2027 revenue outlook
• Positive Sentiment: Needham & Company issued a Buy rating, providing favorable analyst support for PHR following the earnings release. Phreesia Earns Buy Rating from Needham
• Neutral Sentiment: Revenue reached $129.46 million, up 10.4% year over year and slightly above the $129.06 million consensus estimate, indicating continued growth but not a major top-line upside surprise. Phreesia fiscal second-quarter results
• Negative Sentiment: Quarterly EPS was $0.03, below analyst expectations of approximately $0.09 to $0.11, although it improved from $0.01 in the prior-year quarter. The earnings shortfall may weigh on investor sentiment despite the company’s cash-flow progress. Phreesia Q2 earnings and revenues lag estimates

Phreesia Trading Up 0.3%

Shares of Phreesia stock opened at $11.88 on Thursday. Phreesia, Inc. has a twelve month low of $7.77 and a twelve month high of $31.83. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.41. The business has a 50-day moving average price of $11.19 and a 200-day moving average price of $10.48. The firm has a market cap of $734.30 million, a price-to-earnings ratio of 79.20 and a beta of 0.86.

Phreesia (NYSE:PHR) last posted its earnings results on Wednesday, September 2nd. The company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.06). The firm had revenue of $129.46 million during the quarter, compared to analysts’ expectations of $129.06 million. Phreesia had a return on equity of 5.13% and a net margin of 1.85%.Phreesia’s quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.01 earnings per share. Equities research analysts anticipate that Phreesia, Inc. will post 0.39 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts recently issued reports on the company. Wells Fargo & Company reiterated an “equal weight” rating and set a $9.00 target price (down from $15.00) on shares of Phreesia in a research report on Wednesday, May 20th. DA Davidson reissued a “buy” rating and issued a $14.00 price target on shares of Phreesia in a report on Thursday, May 28th. Weiss Ratings upgraded Phreesia from a “sell (d)” rating to a “sell (d+)” rating in a research note on Monday, July 20th. Truist Financial increased their price objective on shares of Phreesia from $11.00 to $12.00 and gave the company a “hold” rating in a report on Thursday, May 28th. Finally, Canaccord Genuity Group reduced their price objective on shares of Phreesia from $22.00 to $16.00 and set a “buy” rating on the stock in a research report on Thursday, May 28th. Nine investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $16.65.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.